Boothbay Fund Management’s Rocket Pharmaceuticals Warrant RCKTW Stock Holding History

Boothbay Fund Management’s Portfolio RCKTW Stock Details RCKTW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$132K	Hold	36,912	–	–	﹤0.01%	1844
2025 Q4	$130K	Hold	36,912	–	–	﹤0.01%	1714
2025 Q3	$120K	Hold	36,912	–	–	﹤0.01%	1713
2025 Q2	$90.4K	Hold	36,912	–	–	﹤0.01%	1318
2025 Q1	$246K	Hold	36,912	–	–	0.01%	1110
2024 Q4	$464K	Hold	36,912	–	–	0.01%	910
2024 Q3	$682K	Hold	36,912	–	–	0.02%	882
2024 Q2	$795K	Hold	36,912	–	–	0.02%	814
2024 Q1	$994K	Hold	36,912	–	–	0.02%	759
2023 Q4	$1.11M	Hold	36,912	–	–	0.03%	697
2023 Q3	$756K	Sell	36,912 -203,321	-85%	-$32.1K	0.02%	879
2023 Q2	$4.77M	Buy	+240,233	New	+$44K	0.1%	225

Other funds holding RCKTW

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

SCM

Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return

SCM

Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return

LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return

AAA

Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return

Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Boothbay Fund Management's RCKTW Position: Q1 2026 in Review

Boothbay Fund Management held its Rocket Pharmaceuticals Warrant (RCKTW) position steady in Q1 2026 at 36,912 shares worth $132K. The position accounts for ﹤0.01% of the portfolio, ranked #1844.

Boothbay Fund Management first reported a position in RCKTW in Q2 2023 and has held it in 12 quarters since. The position peaked at $4.77M in Q2 2023. 10 funds tracked by Wall St. Rank hold RCKTW as of Q1 2026.

Boothbay Fund Management held 36,912 shares of Rocket Pharmaceuticals Warrant worth $132K as of Q1 2026.
Boothbay Fund Management left its Rocket Pharmaceuticals Warrant share count unchanged in Q1 2026.
Rocket Pharmaceuticals Warrant made up ﹤0.01% of Boothbay Fund Management's portfolio in Q1 2026, its #1844 holding.
Boothbay Fund Management first reported a position in Rocket Pharmaceuticals Warrant in Q2 2023 and has held it in 12 quarters since.
Boothbay Fund Management's Rocket Pharmaceuticals Warrant position peaked at $4.77M in Q2 2023.
10 funds tracked by Wall St. Rank held Rocket Pharmaceuticals Warrant as of Q1 2026.

Based on Boothbay Fund Management's 13F filing for Q1 2026, filed 15 May 2026.